Detalhe da pesquisa
1.
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial.
Gut
; 73(3): 459-469, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191268